EN
HI
Pharmaids Pharmaceuticals share price chart
Pharmaids Pharmaceuticals Share Key Metrics
Volume
3197.00
Market Cap
113.70 CR
LTQ@LTP
1@32.56
ATP
32.81
Var Margin
100 %
Circuit Range
25.8-38.68
Delivery %
57.38 %
Value
1.05 L
ASM/GSM
No
Market Lot
1
Summary
PHARMAID stock price is ₹32.56 as of 23 Aug, 2026. The stock intraday movement has stayed between ₹32.00 and ₹33.84, while Pharmaids Pharmaceuticals share price 52 week high low is ₹25.60 & ₹66.00.
In terms of trading activity, PHARMAID share price has recorded a volume of 3,197 shares. The Pharmaids Pharmaceuticals has a market cap of ₹35267812. The stock’s Average Traded Price (ATP) stands at ₹32.81, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹32.56.
The Pharmaids Pharmaceuticals upper circuit limit is ₹38.68 & The Pharmaids Pharmaceuticals lower circuit limit is ₹25.80, with a Value of ₹1.05 L. The Delivery Percentage for the day is 57.38%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Pharmaids Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
2.3
Div. Yield
0
Sector P/E
68.51
Sector P/B
3.35
Sec. Div. Yield
0.51
Pharmaids Pharmaceuticals Resistance and Support
Pivot 32.72
Resistance
First Resistance
34.24
Second Resistance
36.31
Third Resistance
37.83
Support
First Support
30.65
Second Support
29.13
Third Support
27.06
Pharmaids Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 21 2026 | 33.6 | 32.56 | 1.18% | 33.84 | 32 |
| Thu Aug 20 2026 | 34.79 | 32.18 | -2.48% | 34.79 | 31.2 |
| Wed Aug 19 2026 | 34.68 | 33 | 0.03% | 34.68 | 32.16 |
Pharmaids Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-05-29 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-23 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
Pharmaids Pharmaceuticals News
Pharmaids Pharmaceuticals Ltd - 524572 - Board Meeting Outcome for Board Meeting Outcome For August 12, 2026
Pharmaids Pharmaceuticals Board approved Q1 FY27 cons. financial results. The company reported a cons. revenue of ₹4.12 crores and a net profit of ₹1.87 crores, marking a significant turnaround from a ₹5.31 crore loss in the same quarter last year. The board also issued a notice for the 37th Annual General Meeting.
Aug 12 2026 19:32:19
Pharmaids Pharmaceuticals Ltd - 524572 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June 2026.
Pharmaids Pharmaceuticals will hold a board meeting on August 12, 2026. The meeting's agenda includes considering and approving the standalone and consolidated financial results for the quarter ended June 30, 2026.
Aug 06 2026 15:30:15
Pharmaids Pharmaceuticals Management
| Name | Position |
|---|---|
| Prasanna Subramanya Bhat | Company Secretary & Compliance Officer |
| Shankarappa Nagaraja Vinaya Babu | Vice Chairman |
Pharmaids Pharmaceuticals Similar Stocks
Parnax Lab Ltd.
123.35
-0.60 (0.48%)
Bal Pharma Ltd.
86.86
0.85 (0.99%)
Alpa Laboratories Ltd.
62.19
-0.01 (0.02%)
Raaj Medisafe India Ltd.
77.65
3.69 (4.99%)
Mercury Laboratories Ltd.
761.50
-9.80 (1.27%)
Bharat Immunologicals & Biologicals Corporation Ltd.
15.90
-0.05 (0.31%)
Makers Laboratories Ltd.
185.95
11.90 (6.84%)
Everest Organics Ltd.
299.95
-9.05 (2.93%)
Pharmaids Pharmaceuticals FAQs
The Buying Price of Pharmaids Pharmaceuticals share is 32.56 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Pharmaids Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Pharmaids Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Pharmaids Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Pharmaids Pharmaceuticals shares is 2.3. Useful to assess the stock's value relative to its book value.
To assess Pharmaids Pharmaceuticals’s valuation compare Sector P/E, P/B which are 68.51 & 3.35 with sector averages, along with growth rates and financial metrics.
The Market Cap of Pharmaids Pharmaceuticals is 113.70 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Pharmaids Pharmaceuticals share price is 66.00 & 25.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Pharmaids Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
